SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,639.03 544.39
( 0.70%)

Global Indices

Nasdaq

52,497.89 268.83
(0.51%)

Dow Jones

7,510.69 52.06
(0.70%)

Hang Seng

63,705.00 -657.02
(-1.02%)

Nikkei 225

10,879.26 -18.01
(-0.17%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Orchid Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524372

INE191A01027

270.1445747

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ORCHPHARMA

96.52

4998.37

EPS(TTM)

Face Value()

Div & Yield %

10.21

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	921.93	819.37	665.90	556.97	450.70	481.21
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	921.93	819.37	665.90	556.97	450.70	481.21
Other Income	31.93	30.39	58.64	56.97	6.46	24.28
Stock Adjustments	43.85	43.89	21.48	22.73	15.69	20.07
Total Income	997.71	893.65	746.02	636.67	472.85	525.56
EXPENDITURE :
Raw Materials	588.07	528.35	406.10	336.80	244.96	220.38
Power & Fuel Cost	64.98	62.92	61.26	52.74	39.31	47.44
Employee Cost	86.36	69.64	65.35	60.21	64.40	71.60
Other Manufacturing Expenses	42.32	32.65	29.19	26.26	24.26	40.77
Selling & Administrative Expenses	54.76	53.17	34.96	37.77	31.58	58.78
Miscellaneous Expenses	5.36	5.46	7.28	7.22	24.38	112.29
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	841.85	752.20	604.14	521.00	428.89	551.26
Operating Profit	155.85	141.45	141.88	115.67	43.96	-25.71
Interest	14.93	16.71	32.90	33.46	52.21	6.22
Gross Profit	140.92	124.74	108.98	82.21	-8.25	-31.93
Depreciation	34.44	33.22	54.79	87.02	108.90	117.91
Profit Before Tax	106.48	91.52	54.19	-4.81	-117.15	-149.84
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	-3.23	0.00	0.00	0.00	0.00
Reported Net Profit	106.48	94.75	54.19	-4.81	-117.15	-149.84
Extraordinary Items	-0.32	-0.19	40.00	0.51	0.98	0.09
Adjusted Net Profit	106.80	94.94	14.19	-5.32	-118.13	-149.93
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	88.56
P & L Balance brought forward	-1988.38	-2082.68	-2136.64	-2133.29	-2016.74	-1953.57
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.70	0.45	0.23	-1.46	-0.60	1.89
P & L Balance carried down	-1882.60	-1988.38	-2082.68	-2136.64	-2133.29	-2016.74
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	20.99	18.68	13.28	-1.18	-28.70	-36.71
Earnings Per Share(Adj)-Unit Curr	20.99	18.68	13.28	-1.18	-28.70	-36.71
Book Value-Unit Curr	247.54	226.69	162.53	149.30	150.13	178.67
Book Value(Adj)-Unit Curr	247.54	226.69	162.53	149.30	150.13	178.67

78,639.03 544.39 ( 0.70%)

52,497.89 268.83 (0.51%)

7,510.69 52.06 (0.70%)

63,705.00 -657.02 (-1.02%)

10,879.26 -18.01 (-0.17%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)